- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 30, 2025 | 12.81M sh |
| Short Term Investments | Q2 2025 · Mar 31, 2025 | $11.53M |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | $30.23M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $8.29M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $6.9M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $15.57M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $17.2M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $15.87M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $17.57M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $87.01M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $89.37M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $148.96M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $152.19M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 13.34M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 13.47M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $0 |
| Capex | Q2 2025 · Mar 31, 2024 | $3.17M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$6.27M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $142.19M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $146.31M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $132.72M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.32 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.62 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.32 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.63 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $6.55M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $12.37M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $3.86M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $7.47M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$4.33M |
| Net Income | Q2 2025 · Mar 31, 2024 | $8.35M |
| Net Income | Q2 2025 · Dec 31, 2023 | $12.68M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$4.51M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $8.33M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $5.88M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $28.12M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $18.39M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $46.19M |
| Revenue | Q2 2025 · Mar 31, 2024 | $24.27M |
| Revenue | Q2 2025 · Mar 31, 2024 | $74.3M |